SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950123-04-004731
Filing Date
2004-04-16
Accepted
2004-04-16 15:36:44
Documents
2
Group Members
ALEXANDRA INVESTMENT MANAGEMENT, LLCDIMITRI SOGOLOFFMIKHAIL A. FILIMONOV

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G y96324sc13g.txt SC 13G 18290
3 JOINT FILING AGREEMENT y96324exv99w1.txt EX-99.1 1881
  Complete submission text file 0000950123-04-004731.txt   22331
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Subject) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-62471 | Film No.: 04738267
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address ALEXANDRA INVESTMENT MANAGEMENT LLC 767 THIRD AVE 39TH FLOOR NEW YORK NY 10017 2123011800
ALEXANDRA GLOBAL MASTER FUND LTD (Filed by) CIK: 0001266087 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231